OGI — ORGANIGRAM GLOBAL INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1620737 ·
Ontario, Canada
Last close
$0.95
Market Cap
$137.10M
52W High
$2.24
52W Low
$0.85
ADV30
539,655
Next earnings
2026-08-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 105,782,000 | 41,422,000 | 5,330,000 | 105,538,000 | 820,262,000 | 10,851,000 | 334,800,000 |
| Mar 2026 | 59,794,000 | 16,407,000 | -9,793,000 | -921,000 | 521,312,000 | 4,292,000 | 149,500,000 |
| Dec 2025 | 63,538,000 | 23,315,000 | -3,418,000 | 19,969,000 | 530,673,000 | 7,576,000 | 161,217,000 |
| Sep 2025 | 80,061,000 | 31,838,000 | 1,189,000 | -37,964,000 | 562,211,000 | 28,200,000 | 213,081,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,599,000
Investing CF
$-14,969,000
Financing CF
$-2,026,000
CapEx
$-18,528,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.41
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-589,679,000
Inventory
$135,158,000
Receivables
$53,388,000
ST Investments
$811,000
EBIT TTM
$-14,127,000
Pretax Income TTM
$-38,874,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$309,175,008
EBITDA
$16,427,000
Free Cash Flow
$-1,246,500
Enterprise Value
$239,098,816
Total Cash
$11,667,000
Total Debt
$31,652,000
Shares Out
144,152,692
Trailing EPS
$0.44
Book Value
$2.61
ROE
17.6%
ROA
-0.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 259,183,000 | -15,300,000 | -24,759,000 | 562,211,000 | 213,081,000 | 349,130,000 | -7,591,000 |
| Sep 2024 | 159,841,000 | -34,756,000 | -45,440,000 | 407,860,000 | 101,871,000 | 305,989,000 | 3,872,000 |
| Aug 2022 | 145,809,000 | -38,752,000 | -14,283,000 | 577,107,000 | 69,049,000 | 508,058,000 | -36,211,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.02
Max Pain — expiry 2026-12-18
max pain strike: $1.00 · spot: $0.94 · call oi: 3,125 · put oi: 520
Expected Move to 2026-12-18:
±$0.28
(29.15%) —
implied range
$0.67 –
$1.22
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RNA | Atrium Therapeutics, Inc. | $141.29M | $8.26 | — |
| DERM | Journey Medical Corp | $132.24M | $5.95 | — |
| SPRB | SPRUCE BIOSCIENCES, INC. | $130.88M | $45.54 | — |
| TLSA | Tiziana Life Sciences Ltd | $143.80M | $1.13 | — |
| NRXP | NRX Pharmaceuticals, Inc. | $125.12M | $2.89 | — |
News headlines (Yahoo Finance, 1h cache)
Organigram Global Targets Profitable Growth With Canada Focus and German Expansion
2026-09-30 23:02 · Yahoo
Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X
2026-09-30 10:00 · Yahoo
Organigram Global to Host 2026 OG Investor Session
2026-09-02 10:00 · Yahoo
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
2026-08-20 10:00 · Yahoo
Organigram (OGI) Q3 2026 Earnings Call Transcript
2026-08-18 13:42 · Yahoo
Organigram Global Inc (OGI) (Q3 2026) Earnings Call Highlights: Record Revenue and EBITDA ...
2026-08-11 19:00 · Yahoo
Organigram Reports Record Third Quarter Fiscal 2026 Results
2026-08-11 10:00 · Yahoo
Organigram Global Inc. Q3 2026 Earnings Call Summary
2026-08-12 12:30 · Yahoo
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
2026-08-11 13:45 · Yahoo
Organigram Global Q3 Earnings Call Highlights
2026-08-11 13:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.